HIF1A and leukemia: It was reported that HIF-1α activation promotes the expansion of CD133-positive CSCs in brain and pancreatic cancers, whereas HIF-1α deletion decreases leukemia stem cell capacity (Soeda et al., 2009; Bar et al., 2010; Hashimoto et al., 2011; Sun et al., 2020).